跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,298 条关于
“PF-08634404 (SSGJ-707)”
全部
4,298
临床试验
2,362
药物
1,659
机构
14
资讯
263
29天前
Sunshine Guojian Posts 95% Profit Surge as Two Autoimmune Antibodies Win NMPA Approval
10个月前
Pfizer Accelerates PF-08634404 Bispecific Development with Multiple Phase 3 Trials Following $1.25B 3SBio Deal
去年
Pfizer Enters $6 Billion Licensing Deal with China's 3SBio for Novel Cancer Drug
9个月前
Pfizer Advances Two Phase 1 Trials Targeting Kidney Disease and Liver Cancer
8个月前
Pfizer Discontinues Mesothelin-Targeting ADC PF-08052666 Amid Strategic Pipeline Restructuring
7个月前
Pfizer Reports Strong Q2 2025 Performance with Pipeline Advances and Raised Guidance
5年前
First-in-Human Study of PF-06647020 (Cofetuzumab) in Patients with Advanced Solid Tumors
去年
NHS England Proposes Phased Rollout of Tirzepatide for Obesity Treatment
去年
Inavolisib Combination Therapy Doubles Progression-Free Survival in Advanced Breast Cancer
10个月前
Tenpoint Therapeutics Submits First International NDA for BRIMOCHOL PF Presbyopia Treatment in South Korea
第 1 页,共 27 页
上一页
下一页